Dietary Iron Promotes Azoxymethane-Induced Colon Tumors in Mice

Abstract: There is accumulating evidence that high levels of dietary iron may play a role in colon carcinogenesis. We used a mouse model to investigate the impact of elevated dietary iron on incidence of aberrant crypt foci (ACF; a preneoplastic lesion) on tumor formation and on induction of oxidative stress. A/J mice were injected intraperitoneally, once a week for 6 weeks, with the colonotropic carcinogen, azoxymethane (AOM) or saline (vehicle controls). Following AOM or saline treatments, mice were placed on diets of high (3,000 ppm) and low (30 ppm) iron. Mice in each treatment group were sacrificed at 6 and 10 weeks following the final injection with AOM or saline. Colons were removed for subsequent histopathological analysis, which revealed average increases of 4.6 ± 1.3 vs. 10.4 ± 2.5 total tumors at 6 weeks and 30.75 ± 2.7 vs. 41.5 ± 4.4 total tumors at 10 weeks per AOM-treated mouse on low- and high-iron diets, respectively. There were no significant differences in incidence of ACF attributable to iron, although there was a trend toward greater crypt multiplicity per focus in mice on high-iron diets. Notably, no tumors were observed in mice receiving vehicle control injections in place of carcinogen, regardless of the level of dietary iron. These data suggest that iron exerts its effect at the stage of tumor promotion, but is not sufficient to initiate tumor formation. To learn more about mechanisms by which iron promotes tumor growth, colons were assayed for several biomarkers of oxidative stress [BOS; total F2-isoprostanes (F2-IsoPs), 15-F2t-isoprostanes (8-IsoPGF2αs), Isofurans (IsoFs), and 8-hydroxyguanosines (8-OH[d]Gs)], as well as iron absorption, programmed cell death, and cellular proliferation. Elevated PCNA and TUNEL staining of the colon epithelium revealed hyperproliferative and apoptotic responses to iron, while no significant differences between iron groups were observed in each of the BOS that were assayed. Our results suggest that, following carcinogen exposure, elevated dietary iron promotes the growth of tumors with altered cellular homeostasis through a mechanism that is independent of oxidative stress.

[1]  L. E. Anderson,et al.  Oxidative damage in colon and mammary tissue of the HFE-knockout mouse. , 2003, Free radical biology & medicine.

[2]  H. Nakagama,et al.  Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice. , 2003, Gastroenterology.

[3]  J. Fessel,et al.  Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Becker,et al.  Iron-overload induces oxidative DNA damage in the human colon carcinoma cell line HT29 clone 19A. , 2002, Mutation research.

[5]  H. Watanabe,et al.  Combined effect of dietary calcium and iron on colonic aberrant crypt foci, cell proliferation and apoptosis, and fecal bile acids in 1,2-dimethylhydrazine-treated rats. , 2001, Oncology reports.

[6]  S. Toyokuni,et al.  Iron-induced oxidative damage in colon carcinoma (caco-2) cells , 2001, Free radical research.

[7]  Q. S. Wang,et al.  Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis. , 2000, Carcinogenesis.

[8]  N. Žarković,et al.  Involvement of lipid peroxidation, oncogene expression and induction of apoptosis in the antitumorous activity of ferric-sorbitol-citrate. , 2000, Cancer biotherapy & radiopharmaceuticals.

[9]  A. Sesink,et al.  Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme. , 1999, Cancer research.

[10]  W. Pond,et al.  Dietary intrinsic phytate protects colon from lipid peroxidation in pigs with a moderately high dietary iron intake. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[11]  S. Fairweather-Tait,et al.  Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. , 1999, The American journal of clinical nutrition.

[12]  Q. S. Wang,et al.  Azoxymethane-induced colon tumors and aberrant crypt foci in mice of different genetic susceptibility. , 1998, Cancer letters.

[13]  H Clevers,et al.  Adaptive response of iron absorption to anemia, increased erythropoiesis, iron deficiency, and iron loading in beta2-microglobulin knockout mice. , 1998, Blood.

[14]  J. Fischer,et al.  Iron supplementation does not affect cell proliferation or aberrant crypt foci development in the colon of sprague-dawley rats. , 1998, The Journal of nutrition.

[15]  V. Steele,et al.  Enhancement of experimental colon cancer by genistein. , 1997, Cancer research.

[16]  H. Clevers,et al.  In vivo mucosal uptake, mucosal transfer and retention of iron in mice , 1997, Laboratory animals.

[17]  B. Pence,et al.  Dietary lipid and iron modify normal colonic mucosa without affecting phospholipase A2 activity. , 1995, Cancer letters.

[18]  L. Loeb,et al.  Reactive oxygen species in tumorigenesis. , 1994, Cancer research.

[19]  D. Bumann,et al.  Influence of dietary iron overload on cell proliferation and intestinal tumorigenesis in mice. , 1992, Cancer letters.

[20]  J. Freudenheim,et al.  A case-control study of diet and rectal cancer in western New York. , 1990, American journal of epidemiology.

[21]  D. Rosenberg,et al.  Characterization of heme oxygenase in the small intestinal epithelium. , 1989, Archives of biochemistry and biophysics.

[22]  D. Bumann,et al.  Dietary iron enhances the tumor rate in dimethylhydrazine-induced colon carcinogenesis in mice. , 1988, Cancer letters.

[23]  M. Stahlhut,et al.  Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. , 1988, Cancer research.

[24]  J. Maclouf,et al.  Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. , 1985, Analytical chemistry.

[25]  F. A. Putt,et al.  Histopathologic Technic and Practical Histochemistry , 1954, The Yale Journal of Biology and Medicine.

[26]  P. Nambiar,et al.  Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors. , 2003, International journal of oncology.

[27]  I. Johnson,et al.  Nutrient Interactions and Toxicity Research Communication Chronic Exposure to High Levels of Dietary Iron Fortification Increases Lipid Peroxidation in the Mucosa of the Rat Large Intestine , 2001 .

[28]  Owen Rw.  Biomarkers in colorectal cancer. , 2001, IARC scientific publications.

[29]  R. Eitenmiller,et al.  High dietary iron enhances oxidative stress in liver but does not increase aberrant crypt foci development in rats with low vitamin E status. , 1999, Nutrition and cancer.

[30]  Q. S. Wang,et al.  Quantitative assessment of azoxymethane-induced aberrant crypt foci in inbred mice. , 1999, Experimental and molecular pathology.

[31]  J. Morrow,et al.  Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. , 1999, Methods in enzymology.

[32]  S. Fairweather-Tait,et al.  Biochemical and Molecular Roles of Nutrients Increases in the Concentrations of Available Iron in Response to Dietary Iron Supplementation Are Associated with Changes in Crypt Cell Proliferation in Rat , 1998 .

[33]  T. P. Pretlow,et al.  Aberrant crypts in human colonic mucosa: Putative preneoplastic lesions , 1992, Journal of cellular biochemistry. Supplement.

[34]  D. Bumann,et al.  Role of iron in cell proliferation and tumorigenesis. , 1991, Progress in clinical and biological research.

[35]  C. Babbs.  Free radicals and the etiology of colon cancer. , 1990, Free radical biology & medicine.

[36]  J. Maclouf,et al.  Enzyme immunoassays of eicosanoids using acetylcholinesterase. , 1990, Methods in enzymology.

[37]  W. Willett.  Epidemiologic studies of diet and cancer , 1990, Medical oncology and tumor pharmacotherapy.

[38]  J. Maclouf,et al.  Development of a radioimmunoassay for prostaglandin D2 using an antiserum against 11-methoxime prostaglandin D2. , 1986, Prostaglandins.